NEW YORK, Jan. 12 /PRNewswire-USNewswire/ -- Innovations at the intersection of medicine, biotechnology, engineering, physical sciences and information technology are spurring new directions in R&D, commercialization and technology transfer. Basic research in nanomedicine and bionanotechnology is rapidly producing commercially viable products. Governments and industries across the globe are staking their claims by investing billions for research. Clearly, international rivalries are growing and political alliances and battle lines are beginning to gel. The nanotech community will gather at ALM's Strategic Research Institute's "2nd Annual NANOMEDICINE: Commercializing Drug Delivery, Diagnostics and Medical Devices" conference for two days on March 26-27, 2007 in Arlington, VA to discuss the most important applications of nanotechnology in drug delivery, diagnostics and medical devices. The two-day event will consist of presentations, panels and networking opportunities, providing insights into trends in nanomedicine, dissociating myths from realities and highlighting future areas of commercial potential. The previous conference was so successful that a front-page lead cover story covering the conference appeared in Genetic Engineering News. The 2007 event will focus on cutting-edge R&D, commercialization strategies, policy, regulatory and IP issues -- offering networking opportunities to researchers from industry, government and academia; physicians; intellectual property practitioners; business and economic development professionals; technology transfer specialists, policy makers and venture capitalists. For more information on registration, potential speaking engagements, or sponsorship/exhibition opportunities, please contact the organizer, Jon E. Liong of Strategic Research Institute at firstname.lastname@example.org or call (212)967-0095 ext. 243. The conference website is www.srinstitute.com/nano. ABOUT STRATEGIC RESEARCH INSTITUTE The Strategic Research Institute is part of ALM's Conference and Trade Show Division, one of North America's largest producers of educational and networking events for business leaders and the legal profession. The division offers more than 300 conferences and two leading industry tradeshows, as well as conferences in Europe and Asia. Attendance at the division's events, which span a broad range of topics including law, finance, natural resources, life sciences, multi-cultural marketing, real estate and healthcare, will exceed 40,000 executive-level decision makers this year. ABOUT ALM Headquartered in New York City, ALM is a leading integrated media company, focused on the legal and business communities. ALM currently owns and publishes 37 national and regional magazines and newspapers, including The American Lawyer(R), Corporate Counsel(R), The National Law Journal(R) and Real Estate Forum(R). Other ALM businesses include Law.com(R), the Web's leading legal news and information network, Law Journal Press books, newsletter publishing, court verdict and settlement reporting, production of professional educational seminars, market research and content distribution. ALM was formed by U.S. Equity Partners, L.P., a private equity fund sponsored by Wasserstein & Co., LP. More information on ALM's businesses and services is available on the Web at www.alm.com.
SOURCE Strategic Research Institute